Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD.
OBJECTIVE Metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexists with hypertension, yet comparative data on antihypertensive medication classes remain limited. We examined associations between antihypertensive medication class and liver fibrosis and mortality in US adults with MASLD. MET...